Polar Capital Holdings’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Polar Capital Holdings’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,102,740	Closed	-$36.8M	–	330
2024 Q3	$36.8M	Sell	1,102,740 -251,765	-19%	-$8.67M	0.18%	109
2024 Q2	$36.6M	Buy	1,354,505 +49,074	+4%	+$968K	0.22%	99
2024 Q1	$28.2M	Buy	1,305,431 +305,431	+31%	+$6.66M	0.15%	121
2023 Q4	$6.03M	Hold	1,000,000	–	–	0.04%	224
2023 Q3	$5.56M	Buy	+1,000,000	New	+$6.44M	0.04%	219

Polar Capital Holdings's LBPH Position: Q4 2024 in Review

Polar Capital Holdings sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 1,102,740 shares — an estimated $36.8M sold.

Polar Capital Holdings first reported a position in LBPH in Q3 2023 and held it in 5 quarters. The position peaked at $36.8M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Polar Capital Holdings reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Polar Capital Holdings sold 1,102,740 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $36.8M.
Polar Capital Holdings first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
Polar Capital Holdings's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $36.8M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Polar Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.